Industry Updates

THE pharmaceutical watchdog is demanding an urgent explanation from the Pharmacy Guild and the Pfizer drug company over payments to pharmacists for enrolling patients who have been prescribed Pfizer products.

Among the US Trans Pacific Partnership (TPP) proposals leaked today was a proposed chapter on “Transparency and Procedural Fairness for Healthcare Technologies,” more widely known as the Pharmaceutical Pricing Chapter.

Carlyle and Hellman & Friedman agreed to pay $33.25 per PPD share in cash, an almost 30 percent premium over the Wilmington, North Carolina-based company's September 30 closing price.

Every year, the pharmaceutical industry invests billions of dollars in testing drugs that are eventually abandoned because they don’t work or cause side effects.